The Dendra2::tau model allows faster and easier investigation of tau proteostasis and potential identification of pathways that ameliorate tau accumulation and/or promote clearance, which could provide previously unreported molecular targets for treatment of tauopathy. The gene discussed is MAPT; the disease is tauopathy.